Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan E Miller

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal for Immunotherapy of Cancer|October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumorsElizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.
Cancers|November 13, 2025
P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive SurgeryMichail Sideris, Mark R Brincat, Oleg Blyuss, et al.
Molecular Cancer Therapeutics|July 2, 2016
Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with DasatinibRowan E Miller, Rachel Brough, Ilirjana Bajrami, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 27, 2023
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort studyMonika Sobocan, Dhivya Chandrasekaran, Michail Sideris, et al.
The Lancet. Oncology|April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trialToon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2024
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian CancerRanjit Manchanda, Li Sun, Monika Sobocan, et al.
Cancers|September 10, 2021
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST StudyDhivya Chandrasekaran, Monika Sobocan, Oleg Blyuss, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal for Immunotherapy of Cancer|October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumorsElizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.
Cancers|November 13, 2025
P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive SurgeryMichail Sideris, Mark R Brincat, Oleg Blyuss, et al.
Molecular Cancer Therapeutics|July 2, 2016
Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with DasatinibRowan E Miller, Rachel Brough, Ilirjana Bajrami, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 27, 2023
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort studyMonika Sobocan, Dhivya Chandrasekaran, Michail Sideris, et al.
The Lancet. Oncology|April 3, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trialToon Van Gorp, Kathleen N Moore, Gottfried E Konecny, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2024
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian CancerRanjit Manchanda, Li Sun, Monika Sobocan, et al.
Cancers|September 10, 2021
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST StudyDhivya Chandrasekaran, Monika Sobocan, Oleg Blyuss, et al.
Pageof 4